- Home
- CRVO vs AMTX Comparison
CRVO vs AMTX Comparison
Compare CRVO & AMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVO
- AMTX
- Stock Information
- Founded
- CRVO 2001
- AMTX 2005
- Country
- CRVO United States
- AMTX United States
- Employees
- CRVO N/A
- AMTX N/A
- Industry
- CRVO Biotechnology: Pharmaceutical Preparations
- AMTX Major Chemicals
- Sector
- CRVO Health Care
- AMTX Industrials
- Exchange
- CRVO Nasdaq
- AMTX Nasdaq
- Market Cap
- CRVO 95.4M
- AMTX 108.1M
- IPO Year
- CRVO N/A
- AMTX N/A
- Fundamental
- Price
- CRVO $9.80
- AMTX $1.49
- Analyst Decision
- CRVO Strong Buy
- AMTX Strong Buy
- Analyst Count
- CRVO 8
- AMTX 4
- Target Price
- CRVO $25.43
- AMTX $14.56
- AVG Volume (30 Days)
- CRVO 1.5M
- AMTX 804.0K
- Earning Date
- CRVO 05-13-2025
- AMTX 05-08-2025
- Dividend Yield
- CRVO N/A
- AMTX N/A
- EPS Growth
- CRVO N/A
- AMTX N/A
- EPS
- CRVO N/A
- AMTX N/A
- Revenue
- CRVO $9,737,974.00
- AMTX $267,640,000.00
- Revenue This Year
- CRVO N/A
- AMTX $34.74
- Revenue Next Year
- CRVO N/A
- AMTX $82.85
- P/E Ratio
- CRVO N/A
- AMTX N/A
- Revenue Growth
- CRVO 36.29
- AMTX 43.34
- 52 Week Low
- CRVO $1.80
- AMTX $1.31
- 52 Week High
- CRVO $25.69
- AMTX $4.73
- Technical
- Relative Strength Index (RSI)
- CRVO 55.40
- AMTX 40.78
- Support Level
- CRVO $9.03
- AMTX $1.31
- Resistance Level
- CRVO $10.89
- AMTX $1.64
- Average True Range (ATR)
- CRVO 1.90
- AMTX 0.15
- MACD
- CRVO -0.29
- AMTX -0.02
- Stochastic Oscillator
- CRVO 32.37
- AMTX 25.71
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
About AMTX Aemetis Inc. (DE)
Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into advanced biorefineries. It owns and operates an approximately 65 million gallon per year ethanol production facility located in Keyes, California. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. It operates in the reportable geographic segments of North America and India.